nerolidol has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, V; Duraisamy, R; Ganapathy, S; Krishnamoorthy, V; Lakshmanan, V; Sathiavakoo, VA; Veerasamy, V | 1 |
| Balakrishnan, V; Duraisamy, R; Ganapathy, S; Jawaharlal, S; Lakshmanan, V; Veerasamy, V | 1 |
2 other study(ies) available for nerolidol and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Anticancer and antioxidant profiling effects of Nerolidol against DMBA induced oral experimental carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Carcinogenesis; Carcinogens; Carcinoma, Squamous Cell; Cricetinae; Male; Mouth Neoplasms; Sesquiterpenes | 2022 |
Nerolidol assists Cisplatin to induce early apoptosis in human laryngeal carcinoma Hep 2 cells through ROS and mitochondrial-mediated pathway: An in vitro and in silico view.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Humans; Laryngeal Neoplasms; Phosphatidylinositol 3-Kinases; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2022 |